Fundraising Fox

Delfi Diagnostics

Baltimore, US · Founded 2018 · 10 known investors

delfidiagnostics.com ↗

DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening. The test offers an alternative to low-dose CT imaging for patients meeting USPSTF criteria and is made available to health systems, primary care providers, and lung screening programs.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devicesin /delfi-diagnostics

Founders & leadership

PB
Peter BachExecutive Officer
EH
Elizabeth HomansDirector
RG
Rishi GuptaDirector
JK
Justin KaoDirector
JB
Jennifer BuechelExecutive Officer
VV
Victor VelculescuExecutive Officer, Director, Promoter
GY
Greg YapDirector
DS
Douglas SchenkelExecutive Officer
MD
Michael DybbsDirector
JV
Jacob Van NaardenDirector
ND
Nicholas DracopoliExecutive Officer

Investors · 10

AV8 VenturesPalo Alto · $500K – $10M
Foresite CapitalLarkspur
Illumina VenturesFoster City
Menlo VenturesSan Francisco · $1M – $20Mvia Greg Yap · board
Open Field CapitalNew York
OrbiMedNew York · $1M – $75M
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
Samsara BioCapitalPalo Alto
Windham Capital PartnersNew York
Windham Venture PartnersNew York · $1M – $5M

Reported raises · per SEC filings

Form D private placements
▶$34.3MraisedDec 2025 · 50 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter B. BachExecutive Officer
  • Lee-Ann Smith-FreemanExecutive Officer
  • Victor VelculescuDirector
  • Susan TousiExecutive Officer, Director
  • Amoolya SinghExecutive Officer
  • Elizabeth HomansDirector
  • Rishi GuptaDirector
  • Jacob Van NaardenDirector
  • Michael DybbsDirector
  • Greg YapDirector
  • Justin KaoDirector
Offering amount
$60M
Amount sold
$34.3M
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$225MraisedJul 2022 · 44 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter BachExecutive Officer
  • Elizabeth HomansDirector
  • Rishi GuptaDirector
  • Justin KaoDirector
  • Jennifer BuechelExecutive Officer
  • Victor VelculescuExecutive Officer, Director, Promoter
  • Greg YapDirector
  • Douglas SchenkelExecutive Officer
  • Michael DybbsDirector
  • Jacob Van NaardenDirector
  • Nicholas DracopoliExecutive Officer
Offering amount
$225M
Amount sold
$225M
First sale
Jun 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$101.1MraisedJan 2021 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Victor VelculescuExecutive Officer, Director
  • Greg YapDirector
  • Nicholas DracopoliExecutive Officer
  • William StevensExecutive Officer
Offering amount
$101.1M
Amount sold
$101.1M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.5MraisedAug 2019 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nicholas DracopoliExecutive Officer
  • Victor VelculescuExecutive Officer, Director
  • Greg YapDirector
  • William StevensExecutive Officer
Offering amount
$5.5M
Amount sold
$5.5M
First sale
Aug 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.3KraisedAug 2019 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nicholas DracopoliExecutive Officer
  • William J. StevensExecutive Officer
  • Victor VelculescuExecutive Officer, Director
Offering amount
$15.3K
Amount sold
$15.3K
First sale
Jun 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news